Jiao Tai Wan attenuates hepatic lipid accumulation in type 2 diabetes mellitus

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Huang, Zhaoyi ^a   Xu, Xiaohu ^a   Lu, Fuer ^a   Wang, Nan ^a   Chen, Guang ^a   Zhao, Yan ^a   Zou, Xin ^a   Wang, Kaifu ^a   Dong, Hui ^a   Xu, Lijun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CHINESE DRUG; FATTY ACID SYNTHASE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; JIAO TAI WAN; LIPID; METFORMIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DOWN REGULATION; FAT CONTENT; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPOGLYCEMIA; LIFESTYLE MODIFICATION; LIPID LIVER LEVEL; LIPID STORAGE; LIVER; LIVER HISTOLOGY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

EID: 84890093452     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/567045     Document Type: Article

References (38)

1. Nguyen D. M., El-Serag H. B., The Epidemiology of obesity. Gastroenterology Clinics of North America 2010 39 1 1 7 2-s2.0-77349123299 10.1016/j.gtc.2009.12.014
2. Beckman M., Great balls of fat. Science 2006 311 5765 1232 1234 2-s2.0-33644668609 10.1126/science.311.5765.1232 (Pubitemid 43334691)
3. Ali A. T., Ferris W. F., Naran N. H., Crowther N. J., Insulin resistance in the control of body fat distribution: a new hypothesis. Hormone and Metabolic Research 2011 43 2 77 80 2-s2.0-79551605325 10.1055/s-0030-1269851
4. Rasouli N., Molavi B., Elbein S. C., Kern P. A., Ectopic fat accumulation and metabolic syndrome. Diabetes, Obesity and Metabolism 2007 9 1 1 10 2-s2.0-33845544732 10.1111/j.1463-1326.2006.00590.x (Pubitemid 44921036)
5. van Herpen N. A., Schrauwen-Hinderling V. B., Lipid accumulation in non-adipose tissue and lipotoxicity. Physiology and Behavior 2008 94 2 231 241 2-s2.0-42949116365 10.1016/j.physbeh.2007.11.049 (Pubitemid 351615422)
6. Perseghin G., Muscle lipid metabolism in the metabolic syndrome. Current Opinion in Lipidology 2005 16 4 416 420 2-s2.0-22544454497 (Pubitemid 41017625)
7. Lara-Castro C., Garvey W. T., Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome. Endocrinology and Metabolism Clinics of North America 2008 37 4 841 856 2-s2.0-56249108377 10.1016/j.ecl.2008.09.002
8. Shimabukuro M., Higa M., Zhou Y.-T., Wang M.-Y., Newgard C. B., Unger R. H., Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. The Journal of Biological Chemistry 1998 273 49 32487 32490 2-s2.0-0032484132 10.1074/jbc.273.49.32487 (Pubitemid 28557623)
9. Targher G., Bertolini L., Padovani R., Rodella S., Tessari R., Zenari L., Day C., Arcaro G., Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007 30 5 1212 1218 2-s2.0-34247605492 10.2337/dc06-2247 (Pubitemid 46684650)
10. Boettcher E., Csako G., Pucino F., Wesley R., Loomba R., Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis. Alimentary Pharmacology and Therapeutics 2012 35 1 66 75 2-s2.0-83555164835 10.1111/j.1365-2036.2011.04912.x
11. Mazza A., Fruci B., Garinis G. A., Giuliano S., Malaguarnera R., Belfiore A., The role of metformin in the management of NAFLD. Experimental Diabetes Research 2012 2012 2-s2.0-84855572961 10.1155/2012/716404 716404
12. Yi J., Ye X. L., Wang D. Z., He K., Yang Y., Liu X., Li X., Safety evaluation of main alkaloids from Rhizoma Coptidis. Journal of Ethnopharmacology 2013 145 1 303 310
13. Ooi L. S. M., Li Y., Kam S.-L., Wang H., Wong E. Y. L., Ooi V. E. C., Antimicrobial activities of Cinnamon oil and cinnamaldehyde from the Chinese medicinal herb Cinnamomum cassia Blume. The American Journal of Chinese Medicine 2006 34 3 511 522 2-s2.0-33646678386 10.1142/S0192415X06004041 (Pubitemid 43740987)
14. Wang Y., Campbell T., Perry B., Beaurepaire C., Qin L., Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Metabolism 2011 60 2 298 305 2-s2.0-78751647742 10.1016/j.metabol.2010.02.005
15. Khan A., Safdar M., Khan M. M. A., Khattak K. N., Anderson R. A., Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003 26 12 3215 3218 2-s2.0-0345707504 10.2337/diacare.26.12.3215 (Pubitemid 37466877)
16. Yin J., Xing H., Ye J., Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 2008 57 5 712 717 2-s2.0-42949145899 10.1016/j.metabol.2008.01.013 (Pubitemid 351608234)
17. Zhang Y., Li X., Zou D., Liu W., Yang J., Zhu N., Huo L., Wang M., Hong J., Wu P., Ren G., Ning G., Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. Journal of Clinical Endocrinology and Metabolism 2008 93 7 2559 2565 2-s2.0-47549100864 10.1210/jc.2007-2404 (Pubitemid 352008520)
18. Kirkham S., Akilen R., Sharma S., Tsiami A., The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance. Diabetes, Obesity and Metabolism 2009 11 12 1100 1113 2-s2.0-70450209139 10.1111/j.1463-1326.2009.01094.x
19. Gong Y. L., Lu F. E., Dong H., Therapeutic effect of Jiaotaiwan and its single components for the treatment of type 2 diabetes mellitus in rats Zhongguo Yi Yuan Yao Xue Za Zhi 2010 30 5 356 360
20. Folch J., Lees M., Stanley G. H. S., A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry 1957 226 1 497 509 2-s2.0-70449158340
21. Wang N., Dong H., Wei S., Lu F., Application of proton magnetic resonance spectroscopy and computerized tomography in the diagnosis and treatment of nonalcoholic fatty liver disease. Journal of Huazhong University of Science and Technology 2008 28 3 295 298 2-s2.0-45749146650 10.1007/s11596-008-0315-2
22. Dong H., Lu F. E., Zhao L., Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease. Chinese Journal of Integrative Medicine 2012 18 2 152 160
23. Xie W., Gu D., Li J., Cui K., Zhang Y., Effects and action mechanisms of berberine and Rhizoma Coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice. PLoS ONE 2011 6 9 2-s2.0-80052479571 10.1371/journal.pone.0024520 e24520
24. Kim S. H., Choung S. Y., Antihyperglycemic and antihyperlipidemic action of Cinnamomi Cassiae (Cinnamon bark) extract in C57BL/Ks db/db mice. Archives of Pharmacal Research 2010 33 2 325 333 2-s2.0-77949884990 10.1007/s12272-010- 0219-0
25. Li J., Liu T., Wang L., Antihyperglycemic and antihyperlipidemic action of cinnamaldehyde in C57BLKS/J db/db mice. Journal of Traditional Chinese Medicine 2012 32 3 446 452
26. Kasetti R. B., Nabi S. A., Swapna S., Apparao C., Cinnamic acid as one of the antidiabetic active principle(s) from the seeds of Syzygium alternifolium. Food and Chemical Toxicology 2012 50 5 1425 1431 2-s2.0-84858261994 10.1016/j.fct.2012.02.003
27. Szczepaniak L. S., Nurenberg P., Leonard D., Browning J. D., Reingold J. S., Grundy S., Hobbs H. H., Dobbins R. L., Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. American Journal of Physiology: Endocrinology and Metabolism 2005 288 2 E462 E468 2-s2.0-12144259379 10.1152/ajpendo.00064.2004 (Pubitemid 40110657)
28. Mofrad P., Contos M. J., Haque M., Sargeant C., Fisher R. A., Luketic V. A., Sterling R. K., Shiffman M. L., Stravitz R. T., Sanyal A. J., Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003 37 6 1286 1292 2-s2.0-0037566201 10.1053/jhep.2003.50229 (Pubitemid 36667307)
29. Tan B., Ma Y., Shi R., Wang T., Simultaneous quantification of three alkaloids of Coptidis Rhizoma in rat urine by high-performance liquid chromatography: application to pharmacokinetic study. Biopharmaceutics and Drug Disposition 2007 28 9 511 516 2-s2.0-38849115712 10.1002/bdd.578 (Pubitemid 351200989)
30. Li C.-Y., Tsai S.-I., Damu A. G., Wu T.-S., A rapid and simple determination of protoberberine alkaloids in Rhizoma Coptidis by 1H NMR and its application for quality control of commercial prescriptions. Journal of Pharmaceutical and Biomedical Analysis 2009 49 5 1272 1276 2-s2.0-67349270628 10.1016/j.jpba.2009.02.028
31. Chen Y., Ma Y., Ma W., Pharmacokinetics and bioavailability of cinnamic acid after oral administration of ramulus cinnamomi in rats. European Journal of Drug Metabolism and Pharmacokinetics 2009 34 1 51 56 2-s2.0-65649117769
32. Chang X., Yan H., Fei J., Jiang M., Zhu H., Lu D., Gao X., Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats. Journal of Lipid Research 2010 51 9 2504 2515 2-s2.0-77956864571 10.1194/jlr.M001958
33. Kanuri G., Weber S., Volynets V., Spruss A., Bischoff S. C., Bergheim I., Cinnamon extract protects against acute alcohol-induced liver steatosis in mice. The Journal of Nutrition 2009 139 3 482 487 2-s2.0-62749162644 10.3945/jn.108.100495
34. Zhou J. Y., Zhou S. W., Zhang K. B., Tang J. L., Guang L. X., Ying Y., Xu Y., Zhang L., Li D. D., Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. Biological and Pharmaceutical Bulletin 2008 31 6 1169 1176 2-s2.0-45749144363 10.1248/bpb.31.1169 (Pubitemid 351871171)
35. Zhang Q., Xiao X., Feng K., Wang T., Li W., Yuan T., Sun X., Sun Q., Xiang H., Wang H., Berberine moderates glucose and lipid metabolism through multipathway mechanism. Evidence-based Complementary and Alternative Medicine 2011 2011 10 2-s2.0-78349291585 10.1155/2011/924851 924851
36. Hardie D. G., AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nature Reviews Molecular Cell Biology 2007 8 10 774 785 2-s2.0-34648828532 10.1038/nrm2249 (Pubitemid 47462132)
37. Brusq J.-M., Ancellin N., Grondin P., Guillard R., Martin S., Saintillan Y., Issandou M., Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. Journal of Lipid Research 2006 47 6 1281 1288 2-s2.0-33744804815 10.1194/jlr.M600020-JLR200 (Pubitemid 43830720)
38. Kim W. S., Lee Y. S., Cha S. H., Jeong H. W., Choe S. S., Lee M.-R., Oh G. T., Park H.-S., Lee K.-U., Lane M. D., Kim J. B., Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. American Journal of Physiology: Endocrinology and Metabolism 2009 296 4 E812 E819 2-s2.0-65649089100 10.1152/ajpendo.90710.2008